Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo

Bisphosphonates are standard treatments for bone metastases. When given in the adjuvant setting, they reduce breast cancer mortality and recurrence in bone but only among post-menopausal patients. Optimal drug use would require biomarker-based patient selection. Such biomarkers are not yet in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandholm, Jouko, Lehtimäki, Jaakko, Ishizu, Tamiko, Velu, Sadanandan E., Clark, Jeremy, Härkönen, Pirkko, Jukkola-Vuorinen, Arja, Schrey, Aleksi, Harris, Kevin W., Tuomela, Johanna M., Selander, Katri S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349995/
https://www.ncbi.nlm.nih.gov/pubmed/27888633
http://dx.doi.org/10.18632/oncotarget.13570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349995/
https://www.ncbi.nlm.nih.gov/pubmed/27888633
http://dx.doi.org/10.18632/oncotarget.13570

Ejemplares similares